In breast cancer metastasis models, targeting the γδT cell/IL-17/neutrophil axis by neutralizing IL-17 or G-CSF suppressed neutrophil recruitment and reversed the immunosuppressive phenotype of T cells (Figure 3C) [112]. This evidence concerns the gene IL17A and breast cancer.